| 國立臺灣大學 |
2012 |
Early Pathologic Changes and Responses to Treatment in Patients With Later-Onset Pompe Disease
|
Chien, Yin-Hsiu; Lee, Ni-Chung; Huang, Pei-Hsin; Lee, Wang-Tso; Thurberg, Beth L.; Hwu, Wuh-Liang; 胡務亮; 李妮鍾; 簡穎秀; 黃佩欣 |
| 臺大學術典藏 |
2020-12-18T02:21:47Z |
Early pathologic changes and responses to treatment in patients with later-onset Pompe disease
|
Chien Y.-H.; Lee N.-C.; Huang P.-H.; WANG-TSO LEE; Thurberg B.L.; Hwu W.-L. |
| 中國醫藥大學 |
2008-12 |
Early patient contact course: ‘Be a Friend to Patients'
|
廖世傑(Shih-Chieh Liao)*; 許儷絹(Li-Chuan Hsu); 龍紀萱(Chi-Hsuan Lung) |
| 國立成功大學 |
2024 |
EARLY PEOPLING IN AND AROUND TAIWAN: Pleistocene through Middle Holocene Groups before the Austronesian Era
|
Hung;H, -C.;Chao;C, -Y.;Matsumura;H;Carson;M, T. |
| 臺大學術典藏 |
2019-02-25T08:49:05Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Shyr-Chyr Chen; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2019-10-16T08:34:35Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
YAO-MING WU;HSIU-PO WANG;Wang, Chih-Hung;SHYR-CHYR CHEN;KAO-LANG LIU;WAN-CHING LIEN;Wu, Cheng-Yi; Wang, Chih-Hung; Wu, Cheng-Yi; WAN-CHING LIEN; KAO-LANG LIU; HSIU-PO WANG; YAO-MING WU; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-02-11T07:58:29Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wang C.-H.;Wu C.-Y.;Lien W.-C.;Liu K.-L.;Wang H.-P.;Yao-Ming Wu;Chen S.-C.; Wang C.-H.; Wu C.-Y.; Lien W.-C.; Liu K.-L.; Wang H.-P.; YAO-MING WU; Chen S.-C. |
| 臺大學術典藏 |
2020-03-20T08:05:47Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Chen S.-C.; Wang H.-P.; Wu Y.-M.; Lien W.-C.; Liu K.-L.; Wu C.-Y.; CHIH-HUNG WANG; Chen S.-C.;Wu Y.-M.;Wang H.-P.;Liu K.-L.;Lien W.-C.;Wu C.-Y.;CHIH-HUNG WANG |
| 臺大學術典藏 |
2020-03-23T08:17:23Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Chen S.-C.;Wu Y.-M.;Wang H.-P.;Liu K.-L.;WAN-CHING LIEN;Wu C.-Y.;Wang C.-H.; Wang C.-H.; Wu C.-Y.; WAN-CHING LIEN; Liu K.-L.; Wang H.-P.; Wu Y.-M.; Chen S.-C. |
| 臺大學術典藏 |
2019 |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wang C.-H.; Wu C.-Y.; Lien W.-C.; Liu K.-L.; Wang H.-P.; Wu Y.-M.; SHYR-CHYR CHEN; SHYR-CHYR CHEN;Wu Y.-M.;Wang H.-P.;Liu K.-L.;Lien W.-C.;Wu C.-Y.;Wang C.-H. |
| 臺大學術典藏 |
2020-03-27T02:03:19Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wang C.-H.;Wu C.-Y.;Lien W.-C.;Kao-Lang Liu;Wang H.-P.;Wu Y.-M.;Chen S.-C.; Wang C.-H.; Wu C.-Y.; Lien W.-C.; KAO-LANG LIU; Wang H.-P.; Wu Y.-M.; Chen S.-C. |
| 臺大學術典藏 |
2019 |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wang C.-H.; CHENG-YI WU; Lien W.-C.; Liu K.-L.; Wang H.-P.; Wu Y.-M.; Chen S.-C. |
| 臺大學術典藏 |
2020-12-07T07:11:36Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wang C.-H.; Wu C.-Y.; Lien W.-C.; Liu K.-L.; Wang H.-P.; Wu Y.-M.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-12-16T07:56:31Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wang C.-H.;Wu C.-Y.;Lien W.-C.;Liu K.-L.;Wang H.-P.;Wu Y.-M.;Shyr-Chyr Chen; Wang C.-H.; Wu C.-Y.; Lien W.-C.; Liu K.-L.; Wang H.-P.; Wu Y.-M.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-12-28T06:58:34Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Liu K.-L.; WAN-CHING LIEN; Wu C.-Y.; Wang C.-H.; Wang H.-P.; Wu Y.-M.; Chen S.-C. |
| 臺大學術典藏 |
2021-01-15T03:46:27Z |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wang C.-H.; Wu C.-Y.; Lien W.-C.; Liu K.-L.; HSIU-PO WANG; Wu Y.-M.; Chen S.-C. |
| 臺大學術典藏 |
2019 |
Early percutaneous cholecystostomy versus antibiotic treatment for mild and moderate acute cholecystitis: A retrospective cohort study
|
Wu Y.-M.; Chen S.-C.; Wang H.-P.; Liu K.-L.; Lien W.-C.; Wu C.-Y.; CHIH-HUNG WANG |
| 臺大學術典藏 |
2022-08-19T00:20:41Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; CHIUN HSU; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-04-10T12:51:01Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Chiun Hsu;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Chiun Hsu; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-04-28T07:25:14Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Hsu C.-Y.; Chen B.-B.; Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Liang P.-C.;Hsu C.;Chih-Hung Hsu;Cheng A.-L.;Shih T.T.-F.; Liang P.-C.; Hsu C.; CHIH-HUNG HSU; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-09-22T07:39:50Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Chao-Yu Hsu;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-09T02:57:01Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Hsu C.-Y.;Chih-Wei Yu;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-08-06T07:51:44Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; TIFFANY TING-FANG SHIH; Hsu C.-Y.; Chen B.-B. |
| 臺大學術典藏 |
2017 |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; PO-CHIN LIANG; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-31T06:29:36Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; ANN-LII CHENG; Shih T.T.-F. |
